HLN: Bathi resik saben saham (EPS TTM) Haleon plc

Haleon plc dominates the global over-the-counter medicine segment, leveraging the strength of its recognizable brands. This position ensures business resilience during crises and seasonal growth in winter. High barriers to entry and strict regulatory oversight protect the company from new players. The TTM annual earnings per share clearly illustrates this stability, and the value 0.49 currently prices in the current level of profitability.
Ringkesan rincian data analitis Haleon Corp (HLN)

A comparative asset analysis requires an evaluation of EPS TTM as a measure of real profit generation efficiency per share, which allows for the identification of growth deceleration prior to a price reversal. For Haleon plc (HLN), the stability of the company's trailing 12-month net profit per share is sustained through pricing power and cost control via global networks, which secures business margins.